Plasminogen activator inhibitor type 2 in breast cancer.

The serine protease urokinase plasminogen activator (uPA) is causally involved in cancer invasion and metastasis. Activity of this protease in vivo is controlled principally by two inhibitors, one of which is plasminogen activator inhibitor type 2 (PAI-2). In this study, we show that PAI-2 levels we...

Descripción completa

Detalles Bibliográficos
Autores principales: Duggan, C., Kennedy, S., Kramer, M. D., Barnes, C., Elvin, P., McDermott, E., O'Higgins, N., Duffy, M. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228003/
https://www.ncbi.nlm.nih.gov/pubmed/9303361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228003/
https://www.ncbi.nlm.nih.gov/pubmed/9303361

Ejemplares similares